| No. |
Date |
Media |
Broadcasting channel
Newspaper, journal |
Headline, title |
Page |
| 80 |
2025/6/26 |
Web / Newspaper |
Nikkan Kogyo Shimbun |
Developed next-generation mRNA drug technology |
p.28 |
| 79 |
2025/6/26 |
Web |
Iyaku-Tsushin-sha |
Development of Nanomachine to Deliver Nucleic Acid Drugs to Sentinel Lymph Nodes: iCONM and the University of Tokyo |
|
| 78 |
2025/6/25 |
Web |
e cancer |
Strengthening the guard at the checkpoint to prevent cancer metastasis |
|
| 77 |
2025/6/25 |
Web |
Nikkei Biotech |
iCONM: Stiffening the barrier defense and preventing cancer metastasis: Development of nanomachines that deliver nucleic acid drugs to sentinel lymph nodes. |
|
| 76 |
2025/6/25 |
Web |
Nippon-no Kenkyu |
Stiffening the barrier defense and preventing cancer metastasis: Development of nanomachines that deliver nucleic acid drugs to sentinel lymph nodes. |
|
| 75 |
2025/6/24 |
Web |
Nikkei Web |
iCONM and the University of Tokyo Develop Nanomachine to Deliver Nucleic Acid Drugs to Sentinel Lymph Nodes |
|
| 74 |
2025/6/23 |
Web |
Gate2 BioTech |
Precision nanomachines deliver gene therapy to lymph nodes, suppressing breast cancer spread |
|
| 73 |
2025/6/23 |
Web |
Phys & Org |
Precision nanomachines deliver gene therapy to lymph nodes, suppressing breast cancer spread |
|
| 72 |
2025/6/23 |
Web |
Life Technologies |
Innovative Polyplexes Boost Breast Cancer Treatment |
|
| 71 |
2025/6/23 |
Web |
EurekAlert! |
Strengthening the guard at the checkpoint to prevent cancer metastasis |
|
| 70 |
2025/6/18 |
Magazine |
Dream Navi August Issue |
My ON-OFF switching method / Yukihiro Kanda |
p.38 |
| 69 |
2025/6/18 |
YouTube |
Physique at chemie - College de France |
Self-Assembling Polymer Nanosystems: Towards Clinical Translation of Smart Drug Delivery |
|
| 68 |
2025/6/18 |
Newspaper |
Nikkei Shimbun |
Transformation Senzoku Gakuen: Learning and Career Development in the Suburbs |
|
| 67 |
2025/6/17 |
Web |
EurekAlert! |
To ensure that mRNA is delivered stably to the target tissue |
|
| 66 |
2025/6/17 |
Web |
Nikkei Web |
Senzoku Gakuen, off-campus career development, idea generation that outperforms AI, and mock UN |
|
| 65 |
2025/6/15 |
Web/Magazine |
Iyaku-Keizai 6/15 Issue |
Practitioner of medical-engineering collaboration Leading MRI researcher |
p.26 |
| 64 |
2025/6/12 |
Newspaper/Web |
Chemical Daily |
Pseudomonas aeruginosa mRNA Vaccine |
p.6 |
| 63 |
2025/6/11 |
Newspaper |
Nikkei Shimbun |
Shining People: Foreign human resources work hard to build bridges, making the most of their experience to coexist with local communities |
|
| 62 |
2025/6/10 |
Web |
Nikkei Biotech |
Development of next-generation mRNA medicine that automatically adjusts the amount of medicinal protein produced in response to cytosolic factors that are indicators of disease states. |
|
| 61 |
2025/6/10 |
Web |
Nikkei Web |
Kawasaki's experience is utilized to build bridges between the increasing number of foreign human resources and the local community. |
|
| 60 |
2025/6/10 |
Web |
Shimadzu User Interview |
To realize a “Smart Life Care Society” where people around the world can be healthy autonomously |
|
| 59 |
2025/6/4 |
Web |
Nan-Byo Network |
Korea's POSTECH and Kawasaki iCONM Partner on Next-Generation Cell/Gene Therapy Technology - International Collaboration Begins for Treatment of Intractable Diseases |
|
| 58 |
2025/6/4 |
Web |
NNA Asia |
Japanese and Korean Research Institutes Form Alliance to Develop Gene Therapy Drugs |
|
| 57 |
2025/6/3 |
Web |
KSM News |
Postech B-IRC and Japan's iCONM join forces to develop next-generation cell and gene therapeutic drug technology (Korea) |
|
| 56 |
2025/6/3 |
Web |
dkibo |
POSTECH B-IRC and Japan's iCONM sign MOU for joint research on next-generation cell and gene therapy technologies (Korea) |
|
| 55 |
2025/6/3 |
Web |
msn Japan |
Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM |
|
| 54 |
2025/6/3 |
Web |
Iyaku-Tsushin-sha |
iCONM signed a Memorandum of Understanding with Korea Biotechnology Innovation Research Center for joint research and development |
|
| 53 |
2025/6/3 |
Web |
Infoseek |
Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM |
|
| 52 |
2025/6/3 |
Web |
AFPBB News |
Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM |
|
| 51 |
2025/6/3 |
Web |
Korea Wave |
Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM |
|
| 50 |
2025/6/2 |
Web |
msn Korea |
POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea) |
|
| 49 |
2025/6/2 |
Web |
Biz Herald |
POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea) |
|
| 48 |
2025/6/2 |
Web |
daum news |
POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea) |
|
| 47 |
2025/6/2 |
Web |
nate news |
POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea) |
|
| 46 |
2025/6/2 |
Web |
zdnet |
POSTECH to embark on development of cell and gene therapeutics with Japan...MOU exchanged...Biomembrane technology and nano drug delivery system from both institutions combined (KOREA) |
|
| 45 |
2025/6/2 |
Web |
e-science |
POSTECH B-IRC signs MOU with Japan's iCONM on next-generation cell and gene therapy technology (Korea) |
|
| 44 |
2025/6/2 |
Web |
Nikkei Biotech |
iCONM signed a Memorandum of Understanding (MOU) for joint research and development with Korea's BioFuture Technology Innovation Research Center. |
|
| 43 |
2025/6/2 |
Web |
VERITAS |
POSTECH B-IRC and Japan's iCONM sign MOU for joint research on next-generation cell/gene therapy technology (Korea) |
|
| 42 |
2025/6/2 |
Web |
B-IRC / POSTECH |
POSTECH and Japan embark on joint research on next-generation cell and gene therapy technology (Korea) |
|
| 41 |
2025/6/2 |
Web |
Nikkei Biotech |
Transcription factor RUNX1 mRNA drug scheduled for Phase 1 in Australia |
|
| 40 |
2025/6/1 |
Web |
Iyaku-Keizai 6/1 Issue |
Practitioner of medical-engineering collaboration: Developed MRI contrast agent from artificial blood |
p.26 |
| 39 |
2025/6/1 |
Web/Magazine |
Sangyo-Joho Kawasaki
June Issue |
Seminar Information: Development of Novel Antibody DDS Formulations Using DDS, Molecular Imaging, and Cell Biology |
p.3 |
| 38 |
2025/6/1 |
Web/Magazine |
Sangyo-Joho Kawasaki
June Issue |
iCONM Column㉔ Gene therapy with nanomachines using wine ingredients |
p.3 |
| 37 |
2025/6/1 |
Web/Magazine |
Sangyo-Joho Kawasaki
June Issue |
Nano-Medical Innovation Center Celebrates its 10th Anniversary |
p.1-2 |
| 36 |
2025/5/30 |
Newspaper |
Nikkei Shimbun |
NIKKEI Drug Discovery Ecosystem Summit Opening Special Feature: “Transforming the Development and Investment Environment for Breakthrough New Drugs from Japan”. |
p.28-29 |
| 35 |
2025/5/23 |
Newspaper |
Yomiuri Shimbun |
Future Researchers Experience Nanomedicine |
p.22 |
| 34 |
2025/5/23 |
Newspaper |
Kagaku Shimbun |
siRNA medicine for TNBC therapeutic purposes |
p.2 |
| 33 |
2025/5/19 |
Newspaper |
Sekiyu Kagaku Shimbun |
Toagosei develops a drug for treatment of intractable breast cancer / Joint research with iCONM, integrating siRNA and DDS |
|
| 32 |
2025/5/16 |
Web |
Iyaku-Tsushin-sha |
iCONM signed a joint research agreement with Toagosei on an innovative siRNA medicine for triple negative breast cancer treatment. |
|
| 31 |
2025/5/15 |
Web |
iptops.com |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 30 |
2025/5/14 |
Web |
Nikkei Web |
Toagosei enters drug discovery on a full scale, collaborating with Nano-Medical Center to develop drugs for intractable diseases. |
|
| 29 |
2025/5/14 |
Web/Newspaper |
Chemical Daily |
Toagosei-iCONM Collaborate in Nucleic Acid Drug Creation |
７面 |
| 28 |
2025/5/13 |
Web |
Moneyworld |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 27 |
2025/5/13 |
Web |
IRSTREET |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 26 |
2025/5/13 |
Web |
Quick Money World |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 25 |
2025/5/13 |
Web |
Kabutan |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 24 |
2025/5/13 |
Web |
MINKABU |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 23 |
2025/5/13 |
Web |
Nikkei Web |
iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. |
|
| 22 |
2025/5/9 |
Newspaper |
Nikkei Shimbun |
Discovering Humanity: Kazunori Kataoka (3) Making "Fantastic Voyge" a Reality |
p.2 |
| 21 |
2025/5/9 |
Web |
Nikkei Web |
Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (3) |
|
| 20 |
2025/5/9 |
Web |
Nikkei Web |
Making "Fantastic Voyage" a Reality / Kazunori Kataoka, iCONM Center Director |
|
| 19 |
2025/5/8 |
Newspaper |
Nikkei Shimbun |
Discovering Humanity: Kazunori Kataoka (2) Making "Fantastic Voyge" a Reality |
p.2 |
| 18 |
2025/5/8 |
Web |
Nikkei Web |
Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (2) |
|
| 17 |
2025/5/7 |
Newspaper |
Nikkei Shimbun |
Discovering Humanity: Kazunori Kataoka (1) Making "Fantastic Voyge" a Reality |
p.2 |
| 16 |
2025/5/7 |
Web |
Nikkei Web |
Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (1) |
|
| 15 |
2025/5/2 |
Newspaper |
Mainichi Shimbun |
Prejudice against “men's fields”? 10% of women in the Faculty of Engineering |
p.2 |
| 14 |
2025/5/1 |
Web/Magazin |
Sangyo-Joho Kawasaki
May Issue |
Seminar Information: Engineering for Human Body Prof. Kohei Soga, Tokyo University of Science |
p.4 |
| 13 |
2025/5/1 |
Web/Magazin |
Sangyo-Joho Kawasaki
May Issue |
Kanmin-Kogaku Column ⑲ Establishment of nursing IT promotion staffs and DXing of nursing operations initiatives at St. Marianne Medical University Hospital |
p.4 |
| 12 |
4/28/2025 |
Newspaper |
Nikkan Yakugyo |
The Health, Labor and Welfare Committee of the House of Councillors visited “PMDA” and “iCONM” to discuss the Pharmaceutical Affairs Law. |
|
| 11 |
4/24/2025 |
Web |
MSN ReseED |
Diversification of learning school inspection, PTA...Minister of Education, Culture, Sports, Science and Technology 4/22 press conference |
|
| 10 |
4/24/2025 |
Web |
Medifax |
The Health, Labor and Welfare Committee of the House of Councillors visited “PMDA” and “iCONM” to discuss the Pharmaceutical Affairs Law. |
|
| 9 |
4/23/2025 |
Web/Magazine |
iNewsletter 2025-Spring Issue |
Gene therapy with nanomachines loaded with wine ingredients |
p.3 |
| 8 |
4/22/2025 |
Newspaper |
Nihon Keizai Shimbun |
New mRNA Vaccine to be Approved for RS Virus, First Non-Corona Vaccine |
p.5 |
| 7 |
4/21/2025 |
Newspaper |
Nikkei Web |
MHLW subcommittee approves mRNA vaccine for RS virus, the first non-Corona mRNA vaccine. |
|
| 6 |
4/11/2025 |
Newspaper |
Kagaku Shimbun |
Muscular Dystrophy Treatment Success with mRNA Medicine |
p.4 |
| 5 |
4/4/2025 |
Web |
QLife Pro |
Muscular dystrophy, potential for innovative therapeutic development with mRNA medicine |
|
| 4 |
4/3/2025 |
Web |
RareS |
Successful treatment of a mouse model of Duchenne muscular dystrophy (DMD) using mRNA medicine. |
|
| 3 |
4/1/2025 |
Web/Magazine |
KNA News #116 |
Aiming for a safe and comfortable work environment |
p.4 |
| 2 |
4/1/2025 |
Web/Magazine |
Sangyo-Joho Kawasaki
April Issue |
iCONM Column㉓ Innovation Center of NanoMedicine celebrates its 10th anniversary |
p.4 |
| 1 |
3/31/2025 |
Web |
Nikkei Biotech |
PGC-1α mRNA drug delivered by nanomicelle-type carrier and demonstrated the effectiveness in DMD mice |
|
